Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (26 ops.)
Latest filing published 23 Oct 2026 for AGIOS PHARMACEUTICALS, INC., €33k.
Filing timeline
BuySaleSarah Gheuens
Insider track record
Disclosed buys
0
Disclosed sells
26
Signal history
Sarah Gheuens: trading record in brief
Sarah Gheuens, Chief Medical Officer of Agios Pharmaceuticals, Inc., the only issuer in 58 filings published from December 7, 2021 to August 6, 2026, has 22 sales worth EUR 2,332,486 in total, but the median is only EUR 42,971: many small lines around a few larger ones. The three largest are dated August 4, 2026 (EUR 794,065), July 9, 2025 (EUR 357,826) and July 1, 2024 (EUR 151,311). No purchase is recorded. The record is mostly 29 option exercises and 7 grants.
Activity has risen every year: 2 filings in 2021, 8 in 2022, 6 in 2023, 12 in 2024, 19 in 2025 and 11 so far in 2026. The last twelve months hold 17, 8 of them sales. They come out a median of 2 days after the trade.
At Agios Pharmaceuticals, Inc., 18 of Gheuens's trades fall within 30 days of a trade by Brian Goff, 17 of one by Cecilia Jones, 17 of one by James William Burns and 15 of one by Tsveta Milanova, always in the same direction.
Companies and markets linked to Sarah Gheuens
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations62 total
1,489 shares@ US$25.01Common stockSEC:0001439222-26-000122:0
1,489 shares@ US$37.53Common stockSEC:0001439222-26-000122:1
500 shares@ US$25.01Common stockSEC:0001439222-26-000122:2
500 shares@ US$37.52Common stockSEC:0001439222-26-000122:3
30,000 shares@ US$30.480.046% mcap47.8% of flowCommon stockSEC:0001439222-26-000120:0
8,375 sharesCommon stockSEC:0001439222-26-000110:0
2,940 shares@ US$34.71100.0% of flowCommon stockSEC:0001439222-26-000065:1
8,500 shares0Common stockSEC:0001439222-26-000065:0
1,187 shares@ US$28.961.8% of flowCommon stockSEC:0001439222-26-000040:1
1,681 shares@ US$28.962.5% of flowCommon stockSEC:0001439222-26-000040:3
4,000 shares0Common stockSEC:0001439222-26-000040:0
5,666 shares0Common stockSEC:0001439222-26-000040:2
4,000 shares0Common stockSEC:0001439222-26-000040:4
2,932 shares@ US$27.092.2% of flowCommon stockSEC:0001439222-26-000006:1
6,000 shares0Common stockSEC:0001439222-26-000006:0
2,454 shares@ US$43.783.1% of flowCommon stockSEC:0001439222-25-000118:1
2,454 shares@ US$25.013.2% of flowCommon stockSEC:0001439222-25-000118:0
200 shares@ US$43.810.2% of flowCommon stockSEC:0001881190-25-000004:1
200 shares@ US$25.010.3% of flowCommon stockSEC:0001881190-25-000004:0
3,302 shares@ US$43.924.1% of flowCommon stockSEC:0001439222-25-000111:1
3,302 shares@ US$25.014.3% of flowCommon stockSEC:0001439222-25-000111:0
11,067 shares@ US$37.9311.8% of flowCommon stockSEC:0001439222-25-000082:1
847 shares@ US$38.760.9% of flowCommon stockSEC:0001439222-25-000082:2
11,914 shares@ US$25.0115.3% of flowCommon stockSEC:0001439222-25-000082:0
4,091 shares@ US$34.173.9% of flowCommon stockSEC:0001439222-25-000073:1
25 of 62 declarations
